Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Current Opinion in Pharmacology|March 23, 2019
P2X7 purinoceptor as a therapeutic target in muscular dystrophiesDariusz C GóreckiInternational Journal of Molecular Sciences|June 10, 2023
The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular DystrophiesKrzysztof Zabłocki, Dariusz C GóreckiExpert Opinion on Emerging Drugs|August 31, 2006
Emerging vectors and targeting methods for nonviral gene therapyMatthieu D Lavigne, Dariusz C GóreckiActa Biochimica Polonica|October 28, 2006
The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic targetLaura L Yates, Dariusz C GóreckiNeurochemistry International|June 22, 2007
Neuroprotective effects of short peptides derived from the Insulin-like growth factor 1Dariusz C Górecki, Małgorzata Beresewicz, Barbara ZabłockaGene Therapy|April 3, 2025
Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?Dariusz C Górecki, Pawel Kalinski, Joanna PomeroyMethods in Molecular Biology (Clifton, N.J.)|October 25, 2019
Knockout and Knock-in Mouse Models to Study Purinergic SignalingRobin M H Rumney, Dariusz C GóreckiDevelopmental Dynamics : an Official Publication of the American Association of Anatomists|October 11, 2022
Automated multi-sample DNA extraction for genotyping live Xenopus embryosNarmadha Alles, Matthew Guille, Dariusz C GóreckiInternational Journal of Molecular Sciences|October 23, 2021
Disrupted Calcium Homeostasis in Duchenne Muscular Dystrophy: A Common Mechanism behind Diverse ConsequencesBarbara Zabłocka, Dariusz C Górecki, Krzysztof ZabłockiPageof 7